{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:08:16Z","timestamp":1791083296213,"version":"4.1.0"},"reference-count":87,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2009,9,15]],"date-time":"2009-09-15T00:00:00Z","timestamp":1252972800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1000150","type":"journal-article","created":{"date-parts":[[2009,9,14]],"date-time":"2009-09-14T17:58:38Z","timestamp":1252951118000},"page":"e1000150","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":149,"title":["Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and\/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis"],"prefix":"10.1371","volume":"6","author":[{"given":"Dick","family":"Menzies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Paydar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Royce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhukar","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Burman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Vernon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lienhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,9,15]]},"reference":[{"key":"ref1","year":"2008"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1164\/rccm.200802-240OC","article-title":"Influence of multidrug resistance on tuberculosis treatment outcomes with standardized regimens.","volume":"178","author":"A Mak","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"ref3","first-page":"159","article-title":"The mutual assistance programme of the IUATLD. Development, contribution and significance.","volume":"66","author":"A Rouillon","year":"1991","journal-title":"Bull Int Union Tuberc Lung Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1164\/rccm.200805-788ED","article-title":"From threat to reality: the real face of multidrug-resistant tuberculosis.","volume":"178","author":"M Espinal","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"ref5","first-page":"607","article-title":"Time to abandon the standard retreatment regimen with first-line drugs for failures of standard treatment.","volume":"7","author":"MA Espinal","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref6","first-page":"451","article-title":"Inadequacy of the current WHO re-treatment regimen in a central Siberian prison: treatment failure and MDR-TB.","volume":"3","author":"ME Kimerling","year":"1999","journal-title":"Int J Tuber Lung Dis"},{"key":"ref7","first-page":"108","article-title":"Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.","volume":"4","author":"MC Becerra","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref8","first-page":"S231","article-title":"Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946\u20131986, with relevant subsequent publications.","volume":"3","author":"W Fox","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref9","article-title":"Interventions for tuberculosis control and elimination.","author":"HL Rieder","year":"2002","journal-title":"International Union Against Tuberculosis and Lung Disease"},{"key":"ref10","first-page":"183","article-title":"Treatment of tuberculosis.","author":"P Hopewell","year":"2006"},{"key":"ref11","article-title":"Canadian tuberculosis standards","author":"RL Long","year":"2007"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"Treatment of tuberculosis.","volume":"167","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"ref13","article-title":"Tuberculosis guide for low income countries","author":"DA Enarson","year":"2000"},{"key":"ref14","first-page":"e146","article-title":"Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: A systematic review and meta-analysis.","volume":"6(9)","author":"D Menzies","year":"2009","journal-title":"PLoS Med"},{"key":"ref15","first-page":"213","article-title":"Revised international definitions in tuberculosis control.","volume":"5","year":"2001","journal-title":"Int J Tuber Lung Dis"},{"key":"ref16","first-page":"455","article-title":"La rifampicine dans le traitement des tuberculoses chroniques \u00e0 bacilles r\u00e9sistant aux m\u00e9dications standard.","volume":"3\u20134","author":"V Nitti","year":"1969","journal-title":"Acta Tuberc Pneumol Belg"},{"key":"ref17","article-title":"Rifampicin, ethambutol, ethionamide and hydrosan in advanced pulmonary tuberculosis.","author":"PL Salinger","year":"1972","journal-title":"Mediese Tydskrif 354"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jclinepi.2007.03.016","article-title":"The binomial distribution of meta-analysis was preferred to model within-study variability.","volume":"61","author":"TH Hamza","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/sim.1752","article-title":"Controlling the risk of spurious findings from meta-regression.","volume":"23","author":"JPT Higgin","year":"2004","journal-title":"Stat Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/sim.1183","article-title":"Investigating causes of heterogeneity in systematic reviews.","volume":"21","author":"PP Glasziou","year":"2002","journal-title":"Stat Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V","article-title":"Explaining heterogeneity in meta-analysis: a comparison of methods.","volume":"18","author":"SG Thompson","year":"1999","journal-title":"Stat Med"},{"key":"ref22","first-page":"433","article-title":"Drug-resistant tuberculosis in South African gold miners: incidence and associated factors.","volume":"4","author":"GJ Churchyard","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref23","first-page":"320","article-title":"Treatment outcome of relapse and defaulter pulmonary tuberculosis patients.","volume":"6","author":"T Sevim","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref24","first-page":"780","article-title":"Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000.","volume":"6","author":"T Santha","year":"2002","journal-title":"Int J Tuber Lung Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1001\/jama.283.19.2537","article-title":"Standard short-course chemotherapy for drug-resistance tuberculosis - treatment outcomes in 6 countries.","volume":"283","author":"MA Espinal","year":"2000","journal-title":"JAMA"},{"key":"ref26","first-page":"237","article-title":"A comparison of treatment outcome in re-treatment versus new smear positive cases of tuberculosis under RNTCP.","volume":"51","author":"GS Pardeshi","year":"2007","journal-title":"Indian J Public Health"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0041-3879(88)90035-9","article-title":"Controlled clinical trial of a regimen of two durations for the treatment of isoniazid resistant pulmonary tuberculosis.","volume":"69","author":"SO Babu","year":"1988","journal-title":"Tubercle"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-3156.2004.01229.x","article-title":"Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis\u2014a unique approach.","volume":"9","author":"PR Narayanan","year":"2004","journal-title":"Trop Med Int Health"},{"key":"ref29","first-page":"509","article-title":"A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis.","volume":"1","year":"1997","journal-title":"Int J Tuber Lung Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0041-3879(75)90003-3","article-title":"A comparative study of daily followed by twice or once weekly regimens of ethambutol and rifampicin in retreatment of patients with pulmonary tuberculosis.","volume":"56","year":"1975","journal-title":"Tubercle"},{"key":"ref31","first-page":"1","article-title":"A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong.","volume":"55","year":"1974","journal-title":"Tubercle"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(89)91788-1","article-title":"Comparison of daily and twice-weekly regimens to treat pulmonary tuberculosis.","volume":"334","author":"A Castelo","year":"1989","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1164\/arrd.1986.134.5.1056","article-title":"Clinical trial of two short-course (6-month) regimens and a standard regimen (12-month) chemotherapy in retreatment of pulmonary tuberculosis in Pakistan.","volume":"134","author":"A Aziz","year":"1986","journal-title":"Am Rev Resp Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0041-3879(88)90047-5","article-title":"Comparison of a daily and three intermittent retreatment regimens for pulmonary tuberculosis administered under programme conditions.","volume":"69","author":"YP Hong","year":"1988","journal-title":"Tubercle"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0041-3879(76)90047-7","article-title":"A comparative study of daily followed by twice- or once-weekly regimens of ethambutol and rifampicin in the retreatment of patients with pulmonary tuberculosis: second report.","volume":"57","year":"1976","journal-title":"Tubercle"},{"key":"ref36","first-page":"121","article-title":"Retreatment of chronic pulmonary tuberculosis with regimens including high and low doses of rifampicin in the intermittent phase recent and late results - a controlled comparison study.","volume":"51","author":"M Zierski","year":"1976","journal-title":"Bull Int Union Tuberc"},{"key":"ref37","first-page":"550","article-title":"Ambulatory intermittent rifampicin and ethambutol in the retreatment of pulmonary tuberculosis.","volume":"57","author":"N Sriyabhaya","year":"1974","journal-title":"J Med Ass Thailand"},{"key":"ref38","first-page":"132","article-title":"A trial of intermittent rifampicin and ethambutol in retreatment regimens.","author":"M Zierski","year":"1973","journal-title":"Scand J Resp Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(75)91002-8","article-title":"Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore.","volume":"306","year":"1975","journal-title":"Lancet"},{"key":"ref40","first-page":"807","article-title":"Controlled trial of intermittent regimens of rifampin plus isoniazid for pulmonary tuberculosis in Singapore. The results up to 30 months.","volume":"116","year":"1977","journal-title":"Am Rev Respir Dis"},{"key":"ref41","first-page":"171","article-title":"Controlled trial of four twice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis.","volume":"317","year":"1981","journal-title":"Lancet"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0041-3879(90)90037-9","article-title":"Five year results of a 3-month and two 5-month regimens for the treatment of sputum-positive pulmonary tuberculosis in south India.","volume":"71","author":"R Balasubramanian","year":"1990","journal-title":"Tubercle"},{"key":"ref43","first-page":"39","article-title":"Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis: first report.","volume":"118","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0041-3879(80)90012-4","article-title":"Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis. Second report.","volume":"61","year":"1980","journal-title":"Tubercle"},{"key":"ref45","first-page":"219","article-title":"Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.","volume":"118","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0041-3879(79)90001-1","article-title":"Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis: the results up to 24 months.","volume":"60","year":"1979","journal-title":"Tubercle"},{"key":"ref47","first-page":"579","article-title":"Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis.","volume":"119","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0041-3879(81)90016-7","article-title":"Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis: the results up to 30 months.","volume":"62","year":"1981","journal-title":"Tubercle"},{"key":"ref49","first-page":"779","article-title":"Long-term follow-up of a clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis.","volume":"133","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0041-3879(82)80044-5","article-title":"Controlled trial of 4 three-times-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Second report: the results up to 24 months.","volume":"63","year":"1982","journal-title":"Tubercle"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1164\/ajrccm\/136.6.1339","article-title":"Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis.","volume":"136","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"ref52","first-page":"921","article-title":"Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara.","volume":"129","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0041-3879(83)90011-9","article-title":"Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis.","volume":"64","year":"1983","journal-title":"Tubercle"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0041-3879(86)90027-9","article-title":"Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis: final report.","volume":"67","year":"1986","journal-title":"Tubercle"},{"key":"ref55","first-page":"727","article-title":"Controlled clinical trial of two 6-month regimens of chemotherapy in the treatment of pulmonary tuberculosis.","volume":"131","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"ref56","first-page":"374","article-title":"Clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis.","volume":"132","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/ajrccm\/137.5.1147","article-title":"Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis.","volume":"137","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1164\/ajrccm\/139.4.871","article-title":"A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 5 years.","volume":"139","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1164\/ajrccm\/143.2.262","article-title":"A controlled clinical comparison of 6 and 8 months of antituberculosis chemotherapy in the treatment of patients with silicotuberculosis in Hong Kong.","volume":"143","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1164\/ajrccm\/143.4_Pt_1.700","article-title":"Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months.","volume":"143","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1164\/ajrccm\/143.4_Pt_1.707","article-title":"Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis.","volume":"143","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1164\/ajrccm\/140.4.990","article-title":"Controlled clinical trial of levamisole in short-course chemotherapy for pulmonary tuberculosis.","volume":"140","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"ref63","first-page":"27","article-title":"A controlled clinical trial of 3- and 5-month regimens in the treatment of sputum-positive pulmonary tuberculosis in South India.","volume":"134","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"ref64","first-page":"249","article-title":"Short-course (6-month) cooperative tuberculosis study in Poland: results 30 months after completion of treatment.","volume":"124","author":"M Zierski","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"ref65","first-page":"879","article-title":"Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment.","volume":"122","author":"M Zierski","year":"1980","journal-title":"Am Rev Respir Dis"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0041-3879(91)90034-P","article-title":"Short-course chemotherapy for pulmonary tuberculosis under routine programme conditions: a comparison of regimens of 28 and 36 weeks duration in Algeria.","volume":"72","year":"1991","journal-title":"Tubercle"},{"key":"ref67","first-page":"23","article-title":"A controlled trial of 2-month, 3-month, and 12-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis.","volume":"130","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"ref68","first-page":"28","article-title":"Madras study of short-course chemotherapy in pulmonary tuberculosis.","volume":"54","author":"SP Tripathy","year":"1979","journal-title":"Bull Int Union Tuberc"},{"key":"ref69","first-page":"165","article-title":"Controlled clinical trial of five short-course (4 month) chemotherapy regimens in pulmonary tuberculosis.","volume":"123","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"ref70","first-page":"209","article-title":"Essai th\u00e9rapeutique d&apos;une combinaison de trois m\u00e9dicaments essentiels dans la chimioth\u00e9rapie courte de la tuberculose.","volume":"7","author":"D Agounitestane","year":"1990","journal-title":"Rev Mal Resp"},{"key":"ref71","first-page":"209","article-title":"Enqu\u00eate contr\u00f4l\u00e9e comparant trois r\u00e8gimes de chinioth\u00e9rapie quotidienne de six mois dans la tuberculose pulmonaire, en pratique de routine \u00e0 Alger.","volume":"2","author":"L Mazouni","year":"1985","journal-title":"Rev Mal Resp"},{"key":"ref72","first-page":"382","article-title":"Short duration chemotherapy of pulmonary tuberculosis: a pilot trial.","volume":"49","author":"F Poppe de Figeuiredo","year":"1974","journal-title":"Bull Int Union Tuberc"},{"key":"ref73","first-page":"334","article-title":"Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis.","volume":"2","year":"1978","journal-title":"Lancet"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0962-8479(95)90006-3","article-title":"Essai clinique d&apos;une combinaison en proportions fixes de trois medicaments dans le traitement de la tuberculose.","volume":"76","author":"P Chaulet","year":"1995","journal-title":"Tuberc Lung Dis"},{"key":"ref75","first-page":"138","article-title":"A controlled trial of 2-month, 3-month, and 12-month regimens of chemotherapy for sputum smear-negative pulmonary tuberculosis: the results at 30 months.","volume":"124","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"ref76","first-page":"129","article-title":"Low failure rate in standardised retreatment of tuberculosis in Nicaragua: patient category, drug resistance and survival of \u2018chronic\u2019 patients.","volume":"5","author":"E Heldal","year":"2001","journal-title":"Int J Tuber Lung Dis"},{"key":"ref77","first-page":"631","article-title":"Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate?","volume":"7","author":"HT Quy","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(01)06712-5","article-title":"HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers.","volume":"358","author":"P Sonnenberg","year":"2001","journal-title":"Lancet"},{"key":"ref79","first-page":"1461","article-title":"A bibliometric analysis of tuberculosis research indexed in PubMed, 1997\u20132006.","volume":"12","author":"JM Ramos","year":"2008","journal-title":"In J Tuberc Lung Dis"},{"key":"ref80","first-page":"1","article-title":"The Cambridge declaration: towards clinical trials for drug-resistant tuberculosis.","volume":"13","author":"M Espinal","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref81","article-title":"Anti-tuberculosis drug resistance in the world <italic>report no. 4<\/italic>.","year":"2008"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1371\/journal.pmed.0040292","article-title":"Randomized trials to optimize treatment of multidrug-resistant tuberculosis.","volume":"4","author":"CD Mitnick","year":"2007","journal-title":"PLoS Med"},{"key":"ref83","article-title":"Global tuberculosis control.","year":"2008"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1073\/pnas.0600349103","article-title":"Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations.","volume":"103","author":"T Cohen","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3201\/eid1205.050681","article-title":"INH resistance after INH therapy.","author":"Balcells","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"ref86","first-page":"1","year":"2009"},{"key":"ref87","article-title":"Treatment of tuberculosis: Guidelines. 4<sup>th<\/sup> edition","year":"2009"}],"container-title":["PLoS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1000150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T20:01:35Z","timestamp":1540324895000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1000150"}},"subtitle":[],"editor":[{"given":"Megan","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,9,15]]},"references-count":87,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2009,9,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1000150","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1247963.716063","asserted-by":"object"}]},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,15]]}}}